Skip navigation

Eisai Co. Ltd.

Pharmaceuticals
Japan
2016 Revenue (US$ Millions)$4,609
Revenue Growth (%)-1.61%
Net Income (US$ Millions)$337
Earnings Per Share (US$)$1.17
EPS Growth Rate (%)-28.34%
Profit Margin7.30%
Total Equity (US$ Millions)$4,999
Return on Equity (%)6.86%
Long Term Debt (US$ Millions)$0
Debt To Equity Ratio (%)0.00%
Total Assets (US$ Millions)$8,813
Current Assets (US$ Millions)$4,139
Current Liabilities (US$ Millions)$1,913
Cost of Goods Sold (US$ Millions)$1,675
Inventory Turnover2.50